The Supreme Court recently heard oral arguments in the matter of Assocation of Molecular Pathology v. Myriad Genetics
and is now faced with the task of determining whether the two human genes linked to breast and ovarian cancer can be patented. Join SABA-DC and our speaker, Raj Davé
, as we discuss this important case, the current state of the law, and the implications for science and research. Space is limited, so please RSVP to email@example.com
by May 20.
Date: Wednesday, May 22, 2013
Where: Cedar, 822 E St NW, Washington, DC
Time: 7:00pm to 9:00pm
Cost: The cost of your dinner
A partner at Pillsbury Winthrop Shaw Pittman, Dr. Davé focuses on strategic intellectual property counseling, patent prosecution, dispute resolution, licensing, technology transactions, intellectual property mining and enforcement, reexamination and reissue practice, pre-litigation opinions and patent litigation.
He represents U.S. and foreign clients in the areas of chemistry, biotechnology, physical science, materials and polymer science, life science, nanotechnology and electronics, in matters relating to biochips, bioinformatics, biophysics, biomedical, business method, combinatorial chemistry, composites and polymers, digital health, fuel cell, holographic and magnetic media, information technology, internet and software, lasers, medical devices, micro-electro-mechanical system (MEMS), optics, pharmaceuticals, telecommunications and wireless devices. Dr. Davé experience includes counseling relating to ANDA challenges and generic drug litigation.